Joint ESC/EASD guidelines on diabetes, where are we Now and where should we Go?

Current Vascular Pharmacology

Volumn 10, Issue 6, 2012, Pages 690-692

  Rydén, Lars ^a   Mellbin, Linda ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Diabetes; Guidelines; Management; Prediabetes

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CARDIOLOGIST; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DYSGLYCEMIA; FAT INTAKE; HAZARD RATIO; HUMAN; IMPAIRED GLUCOSE TOLERANCE; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; SALT INTAKE; SMOKING CESSATION;

CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; HUMANS; HYPOGLYCEMIC AGENTS; PRACTICE GUIDELINES AS TOPIC; PREDIABETIC STATE; RISK REDUCTION BEHAVIOR;

EID: 84870213610     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112803520891     Document Type: Article

References (16)

1. International Diabetes Federation 2011. Global Burden: Prevalence and Projections, 2011 and 2030. Available from http://www. diabetesatlas.org/content/diabetes-and-impairedglucose-tolerance.
2. Tierney EF, Geiss LS, Engelgau MM, et al. Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am J Public Health 2001; 91: 84-92.
3. Henriksson F, Agardh C-D, Berne C, et al. Direct medical costs for patients with type 2 diabetes in Sweden. J Intern Med 2000; 248: 387-96.
4. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-22.
5. Norhammar A, Lindbäck J, Rydén L, Wallentin L, Stenestrand U; Register of Information and Knowledge about Swedish Heart Intensive Care Admission (RIKS-HIA). Improved but still high shortand long-term mortality rates after myocardial infarction in patients with diabetes mellitus: a time-trend report from the Swedish Register of Information and Knowledge about Swedish Heart Intensive Care Admission. Heart J 2007; 93:1577 and available at: SWEDEHEART http://www.ucr.uu.se/swedeheart/index.php/arsrapporter)
6. Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, prediabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Europ Heart J Suppl 2007; 9: C3.
7. International Diabetes Federation. Guideline for management of post meal glucose. Available from http://www.idf.org
8. Deedwania P, Kosiborod M, Barrett E, et al. American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2008; 117: 1610. Erratum in: Circulation 2010; 121: e444.
9. Nathan DM, Buse JB, Davidson MB, et al.; American Diabetes Association; European Association for the Study of Diabetes. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009; 52: 17-30.
10. American Diabetes Organisation. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33 (Suppl 1): S11.
11. Czupryniak L. Diabetes Guidelines for the management of diabetes: is ADA and EASD consensus more clinically relevant than IDF recommendations? Res Clin Practi 2009; 86: S 22.
12. Anselmino M, Malmberg K, Öhrvik J, Rydén L. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008; 15: 216-23.
13. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Reiner Z, Keil U; EUROASPIRE Study Group. EUROASPIRE III. Management of cardiovascular risk factors in asymptomatic highrisk patients in general practice: cross-sectional survey in 12 European countries. Eur J Cardiovasc Prev Rehabil 2010; 17: 530-40.
14. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyörälä K, Keil U; EUROASPIRE Study Group. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009; 373: 929-40.
15. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-91.
16. Anselmino M, Malmberg K, Öhrvik J, Rydén L. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur J Cardiovasc Prev Rehabil 2008; 15: 216-23.